No evidence of an association between norepinephrine transporter gene polymorphisms and attention deficit hyperactivity disorder: A family-based and case-control association study in a Korean sample

Soo Churl Cho, Jae Won Kim, Boong Nyun Kim, Jun Won Hwang, Mira Park, Soon Ae Kim, Dae Yeon Cho, Hee Jeong Yoo, Un Sun Chung, Jung Woo Son, Tae Won Park

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Neurobiological and pharmacological research has suggested that dysregulation of the central noradrenergic systems might be involved in the pathophysiology of attention deficit hyperactivity disorder (ADHD). Previous studies have demonstrated that the norepinephrine transporter gene (SLC6A2) is associated with ADHD. The aims of this study were to examine the association of the SLC6A2 G1287A and -3081(A/T) polymorphisms with ADHD in Korean children and adolescents, and to determine the relationships of the genotypes of these two polymorphisms with continuous performance test results and the Junior Temperament and Character Inventory profiles of ADHD. In a case-control study, we assessed 186 ADHD probands and 150 normal controls; 109 trios were studied in a family-based association analysis. There were no significant differences in the genotype or allele frequencies of the SLC6A2 G1287A and -3081(A/T) polymorphisms between the ADHD and control groups (p > 0.05). In the transmission disequilibrium test analyses, there was no evidence for biased transmission of any of the alleles of the SLC6A2 G1287A and -3081(A/T) polymorphisms. In the haplotype analyses of these two polymorphisms, the global and individual χ2 tests showed no significant associations between any of the haplotypes and ADHD. There were no significant differences with respect to the continuous performance test results and the Junior Temperament and Character Inventory profiles in the ADHD probands according to the genotypes of the SLC6A2 G1287A and -3081(A/T) polymorphisms. Our findings do not support SLC6A2 as a major genetic susceptibility factor in ADHD.

Original languageEnglish
Pages (from-to)131-138
Number of pages8
JournalNeuropsychobiology
Volume57
Issue number3
DOIs
StatePublished - 1 Jul 2008

Fingerprint

Norepinephrine Plasma Membrane Transport Proteins
Attention Deficit Disorder with Hyperactivity
Case-Control Studies
Genes
Temperament
Genotype
Haplotypes
Equipment and Supplies
Genetic Predisposition to Disease
Gene Frequency
Alleles
Pharmacology

Keywords

  • Attention deficit hyperactivity disorder
  • Continuous performance test
  • Haplotype
  • Junior Temperament and Character Inventory
  • SLC6A2
  • Transmission disequilibrium

Cite this

@article{c803f327873f4ede88b08cf668532305,
title = "No evidence of an association between norepinephrine transporter gene polymorphisms and attention deficit hyperactivity disorder: A family-based and case-control association study in a Korean sample",
abstract = "Neurobiological and pharmacological research has suggested that dysregulation of the central noradrenergic systems might be involved in the pathophysiology of attention deficit hyperactivity disorder (ADHD). Previous studies have demonstrated that the norepinephrine transporter gene (SLC6A2) is associated with ADHD. The aims of this study were to examine the association of the SLC6A2 G1287A and -3081(A/T) polymorphisms with ADHD in Korean children and adolescents, and to determine the relationships of the genotypes of these two polymorphisms with continuous performance test results and the Junior Temperament and Character Inventory profiles of ADHD. In a case-control study, we assessed 186 ADHD probands and 150 normal controls; 109 trios were studied in a family-based association analysis. There were no significant differences in the genotype or allele frequencies of the SLC6A2 G1287A and -3081(A/T) polymorphisms between the ADHD and control groups (p > 0.05). In the transmission disequilibrium test analyses, there was no evidence for biased transmission of any of the alleles of the SLC6A2 G1287A and -3081(A/T) polymorphisms. In the haplotype analyses of these two polymorphisms, the global and individual χ2 tests showed no significant associations between any of the haplotypes and ADHD. There were no significant differences with respect to the continuous performance test results and the Junior Temperament and Character Inventory profiles in the ADHD probands according to the genotypes of the SLC6A2 G1287A and -3081(A/T) polymorphisms. Our findings do not support SLC6A2 as a major genetic susceptibility factor in ADHD.",
keywords = "Attention deficit hyperactivity disorder, Continuous performance test, Haplotype, Junior Temperament and Character Inventory, SLC6A2, Transmission disequilibrium",
author = "Cho, {Soo Churl} and Kim, {Jae Won} and Kim, {Boong Nyun} and Hwang, {Jun Won} and Mira Park and Kim, {Soon Ae} and Cho, {Dae Yeon} and Yoo, {Hee Jeong} and Chung, {Un Sun} and Son, {Jung Woo} and Park, {Tae Won}",
year = "2008",
month = "7",
day = "1",
doi = "10.1159/000138916",
language = "English",
volume = "57",
pages = "131--138",
journal = "Neuropsychobiology",
issn = "0302-282X",
publisher = "S. Karger AG",
number = "3",

}

No evidence of an association between norepinephrine transporter gene polymorphisms and attention deficit hyperactivity disorder : A family-based and case-control association study in a Korean sample. / Cho, Soo Churl; Kim, Jae Won; Kim, Boong Nyun; Hwang, Jun Won; Park, Mira; Kim, Soon Ae; Cho, Dae Yeon; Yoo, Hee Jeong; Chung, Un Sun; Son, Jung Woo; Park, Tae Won.

In: Neuropsychobiology, Vol. 57, No. 3, 01.07.2008, p. 131-138.

Research output: Contribution to journalArticle

TY - JOUR

T1 - No evidence of an association between norepinephrine transporter gene polymorphisms and attention deficit hyperactivity disorder

T2 - A family-based and case-control association study in a Korean sample

AU - Cho, Soo Churl

AU - Kim, Jae Won

AU - Kim, Boong Nyun

AU - Hwang, Jun Won

AU - Park, Mira

AU - Kim, Soon Ae

AU - Cho, Dae Yeon

AU - Yoo, Hee Jeong

AU - Chung, Un Sun

AU - Son, Jung Woo

AU - Park, Tae Won

PY - 2008/7/1

Y1 - 2008/7/1

N2 - Neurobiological and pharmacological research has suggested that dysregulation of the central noradrenergic systems might be involved in the pathophysiology of attention deficit hyperactivity disorder (ADHD). Previous studies have demonstrated that the norepinephrine transporter gene (SLC6A2) is associated with ADHD. The aims of this study were to examine the association of the SLC6A2 G1287A and -3081(A/T) polymorphisms with ADHD in Korean children and adolescents, and to determine the relationships of the genotypes of these two polymorphisms with continuous performance test results and the Junior Temperament and Character Inventory profiles of ADHD. In a case-control study, we assessed 186 ADHD probands and 150 normal controls; 109 trios were studied in a family-based association analysis. There were no significant differences in the genotype or allele frequencies of the SLC6A2 G1287A and -3081(A/T) polymorphisms between the ADHD and control groups (p > 0.05). In the transmission disequilibrium test analyses, there was no evidence for biased transmission of any of the alleles of the SLC6A2 G1287A and -3081(A/T) polymorphisms. In the haplotype analyses of these two polymorphisms, the global and individual χ2 tests showed no significant associations between any of the haplotypes and ADHD. There were no significant differences with respect to the continuous performance test results and the Junior Temperament and Character Inventory profiles in the ADHD probands according to the genotypes of the SLC6A2 G1287A and -3081(A/T) polymorphisms. Our findings do not support SLC6A2 as a major genetic susceptibility factor in ADHD.

AB - Neurobiological and pharmacological research has suggested that dysregulation of the central noradrenergic systems might be involved in the pathophysiology of attention deficit hyperactivity disorder (ADHD). Previous studies have demonstrated that the norepinephrine transporter gene (SLC6A2) is associated with ADHD. The aims of this study were to examine the association of the SLC6A2 G1287A and -3081(A/T) polymorphisms with ADHD in Korean children and adolescents, and to determine the relationships of the genotypes of these two polymorphisms with continuous performance test results and the Junior Temperament and Character Inventory profiles of ADHD. In a case-control study, we assessed 186 ADHD probands and 150 normal controls; 109 trios were studied in a family-based association analysis. There were no significant differences in the genotype or allele frequencies of the SLC6A2 G1287A and -3081(A/T) polymorphisms between the ADHD and control groups (p > 0.05). In the transmission disequilibrium test analyses, there was no evidence for biased transmission of any of the alleles of the SLC6A2 G1287A and -3081(A/T) polymorphisms. In the haplotype analyses of these two polymorphisms, the global and individual χ2 tests showed no significant associations between any of the haplotypes and ADHD. There were no significant differences with respect to the continuous performance test results and the Junior Temperament and Character Inventory profiles in the ADHD probands according to the genotypes of the SLC6A2 G1287A and -3081(A/T) polymorphisms. Our findings do not support SLC6A2 as a major genetic susceptibility factor in ADHD.

KW - Attention deficit hyperactivity disorder

KW - Continuous performance test

KW - Haplotype

KW - Junior Temperament and Character Inventory

KW - SLC6A2

KW - Transmission disequilibrium

UR - http://www.scopus.com/inward/record.url?scp=47949097303&partnerID=8YFLogxK

U2 - 10.1159/000138916

DO - 10.1159/000138916

M3 - Article

C2 - 18552510

AN - SCOPUS:47949097303

VL - 57

SP - 131

EP - 138

JO - Neuropsychobiology

JF - Neuropsychobiology

SN - 0302-282X

IS - 3

ER -